ArcherDX is now Invitae, bringing the future of precision oncology to cancer care. The transaction was completed in October 2020. Learn more here.
Invitae’s Anchored Multiplex PCR (AMP™) chemistry is now available in the EU as a CE-marked IVD test for your lab. Learn more.